Wallace Owen B.
Insider CIK 1778843 · FULC Chief Scientific Officer · GLUE Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 119,000 | — | $0 | 119,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-01-03 | 2023-01-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-03-01 | 2022-03-02 | 117,450 | — | $0 | 117,450 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 113,298 | — | $0 | 113,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-04-12 | 2021-06-25 | 387,069 | — | $0 | 387,069 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-09-14 | 2020-09-14 | 6,350 | — | $0 | 75,592 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-09-14 | 2020-09-14 | 6,350 | $7.84 | $49.8K | 133,438 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-07-08 | 2020-07-09 | 2,951 | — | $0 | 81,942 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-07-08 | 2020-07-09 | 2,951 | $20.00 | $59.0K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-07-08 | 2020-07-09 | 2,951 | $7.84 | $23.1K | 130,039 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-30 | 2020-07-01 | 141 | — | $0 | 84,893 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-30 | 2020-07-01 | 141 | $7.84 | $1.1K | 127,229 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-30 | 2020-07-01 | 141 | $20.00 | $2.8K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-28 | 2020-06-01 | 2,232 | — | $0 | 85,034 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-28 | 2020-06-01 | 2,232 | $20.00 | $44.6K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-28 | 2020-06-01 | 2,232 | $7.84 | $17.5K | 129,320 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-27 | 2020-05-29 | 448 | — | $0 | 87,266 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-27 | 2020-05-29 | 448 | $7.84 | $3.5K | 127,536 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-27 | 2020-05-29 | 448 | $20.00 | $9.0K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-26 | 2020-05-28 | 412 | — | $0 | 87,714 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-26 | 2020-05-28 | 412 | $7.84 | $3.2K | 127,500 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-26 | 2020-05-28 | 412 | $20.00 | $8.2K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-02-19 | 2020-02-20 | 6,088 | — | $0 | 88,126 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-02-19 | 2020-02-20 | 6,088 | $20.00 | $121.8K | 127,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-02-19 | 2020-02-20 | 6,088 | $7.84 | $47.7K | 133,176 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-27 | 58,900 | — | $0 | 58,900 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2019-07-18 | 2019-07-18 | 44,493 | — | $0 | 44,493 | SEC↗ |